BenevolentAI

5 statements across 1 episodes · 2 bullish · 0 bearish · 1 people on the record · first statement Oct 26, 2017 by Jerome Pesenti · said 8 times in 2 episodes since 2017 · across every show →

Mentions by year

brought up most by Jerome Pesenti (8)

tap a year for its mentions
0041812017201820192020episodesmentions
0112017201820192020episodes it came up in
0040.5812017201820192020episodesmentions per episode

every mention, scene by scene, with the transcript →

Everything said about BenevolentAI, oldest first

Oct 26, 2017 positive
Disclosure
BenevolentAI has initiated a Phase II clinical trial
“We actually started just now. A clinical trial phase two, so we're going all the way from, ah, the AI to the actual clinical trials.”
Jerome Pesenti Oct 26, 2017 ▶ 3:05 Using AI to Accelerate Drug Discovery // Jerome Pesenti, BenevolentAI (FirstMark's Data Driven)
Oct 26, 2017 neutral
Disclosure
BenevolentAI is exploring applying its AI platform to battery technology
“And our vision is that if we can do that for drugs, we may do that also for materials. We are actually looking at battery technology.”
Jerome Pesenti Oct 26, 2017 ▶ 18:21 Using AI to Accelerate Drug Discovery // Jerome Pesenti, BenevolentAI (FirstMark's Data Driven)
Oct 26, 2017 positive
Assertion Not checkable as stated
Two AI-generated ALS compounds outperformed standard-of-care treatments in lab validation
“We actually put the five hypothesis in the lab, and at this point, it's in vitro and in vivo validation, and, you know, two of them didn't work well one of them work as well as this kind of standard of care at the moment, and two of them work actually much bet…”
Jerome Pesenti Oct 26, 2017 ▶ 17:42 Using AI to Accelerate Drug Discovery // Jerome Pesenti, BenevolentAI (FirstMark's Data Driven)
Oct 26, 2017 neutral
Assertion Not checkable as stated
BenevolentAI's biological knowledge graph contains approximately one billion facts
“Think of it as like a billion facts, ok?”
Jerome Pesenti Oct 26, 2017 ▶ 7:27 Using AI to Accelerate Drug Discovery // Jerome Pesenti, BenevolentAI (FirstMark's Data Driven)
Oct 26, 2017 neutral
Disclosure
BenevolentAI cannot discover unstudied targets; it only repurposes existing knowledge
“We don't come up with new targets that have never been looked at. For example, the system by definition cannot do that. So it's always about repurposing some existing knowledge.”
Jerome Pesenti Oct 26, 2017 ▶ 25:54 Using AI to Accelerate Drug Discovery // Jerome Pesenti, BenevolentAI (FirstMark's Data Driven)
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 400 conversations transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.